JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hill, B. J. F.
Right arrow Articles by Sturek, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hill, B. J. F.
Right arrow Articles by Sturek, M.

Vol. 295, Issue 2, 484-491, November 2000


Enhanced EndothelinA Receptor-Mediated Calcium Mobilization and Contraction in Organ Cultured Porcine Coronary Arteries1

Brent J. F. Hill, Laxmansa C. Katwa, Brian R. Wamhoff and Michael Sturek

Vascular Biology Laboratory, Dalton Cardiovascular Research Center, and Department of Physiology, School of Medicine, University of Missouri, Columbia, Missouri (B.J.F.H., B.R.W., M.S.); and Department of Physiology, School of Medicine, East Carolina University, Greenville, North Carolina (L.C.K.)

    Abstract
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Arterial injury models for coronary artery disease have demonstrated an enhanced expression and function of either the endothelinA or endothelinB (ETA or ETB) receptor subtype. We hypothesized that organ culture would enhance the physiological function of ET receptors in the porcine right coronary artery. Arteries were either cold stored (4°C) or organ cultured (37°C) for 4 days. After 4 days, the artery was either 1) sectioned into rings to measure the ET-1-induced isometric tension response (3 × 10-10-3 × 10-7 M), or 2) enzymatically dispersed and the isolated smooth muscle cells imaged using fura-2 to measure the myoplasmic calcium (Cam) response to 3 × 10-8 M ET-1 (~EC50). Isometric tension and Cam to ET-1 were measured in the absence and presence of bosentan (nonselective ETA or ETB receptor antagonist), BQ788 (ETB-selective antagonist), and BQ123 (ETA-selective antagonist). Compared with cold storage, organ culture induced a 2-fold increase in tension development (3 × 10-7 M ET-1) and Cam (3 × 10-8 M ET-1), which was inhibited with bosentan, thus confirming the enhanced responses to ET-1 were due to ET receptor activation. BQ123 also inhibited the enhanced contraction and Cam responses to ET-1. In contrast, BQ788 failed to inhibit tension development and Cam responses to ET-1 in organ culture and cold storage. Sarafotoxin 6C (ETB agonist) failed to elicit an increased Cam response in organ culture compared with cold storage. Our results indicate the increased tension development and Cam responses to ET-1 in organ culture are attributable to ETA receptors, and not ETB receptors.

    Introduction
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Endothelin-1 (ET-1) is a potent vasoconstrictor and mitogen of vascular smooth muscle cells (Harrison et al., 1992; Mathew et al., 1996). Smooth muscle cells contain both the ETA and ETB receptor subtypes; however, the relative subtype distribution varies depending on the vessel type (Godfraind, 1993; Adner et al., 1998a). In coronary arteries the ETA receptor subtype predominates; approximately 80% of the contractile response is attributed to the ETA receptor, whereas ETB is responsible for the remaining 20% (Dagassan et al., 1996; Elmoselhi and Grover, 1997).

The selective up-regulation of either subtype is enhanced with the progression of atherosclerosis, thrombosis, and cardiac hypertrophy (Wang et al., 1995; Mathew et al., 1996; Stewart, 1998). Evidence suggests either ET receptor subtype may contribute to the enhanced contractile response to ET with arterial injury (Harrison et al., 1992; Wang et al., 1995; Dagassan et al., 1996; White et al., 1998). Coronary artery disease is a leading cause of death in the U.S. population (Russell et al., 1998); therefore, it is important to understand the role of ET-1 receptors in this artery. Few investigators have studied the functional response to ET-1 in a coronary artery injury model. Dagassan et al. (1996) described an up-regulation of ETB receptors in the left anterior descending (LAD) coronary artery from humans displaying atherosclerosis. Hasdai et al. (1997) also found enhanced ETB-mediated vasoconstriction in the left circumflex coronary artery from hyperlipidemic pigs. In contrast, Katwa et al. (1999) and Wang et al. (1995) demonstrated increased ETA function in the right coronary artery and the LAD coronary artery, respectively, with arterial injury. However, Godfraind (1993) found that there is a high degree of heterogeneity of ETA and ETB receptors along the length of the LAD. ET-1-induced contractions are mediated almost entirely by ETA receptors at the distal end of the LAD, whereas ETB receptors are partially responsible for the contraction at the proximal end. To eliminate this large degree of heterogeneity we used the right coronary artery because it has a predominant ETA receptor population that is responsible for mediating vasoconstriction (Bacon and Davenport, 1996; Schiffrin and Touyz, 1998). In this study we hypothesized that arterial injury (i.e., organ culture) would enhance ET receptor-mediated vasoconstriction and myoplasmic calcium (Cam) responses in the porcine right coronary artery.

Organ culture is a technique that has been used to study cell proliferation in vessels (Gotlieb and Boden, 1984; Newby and Zaltsman, 1999; Voisard et al., 1999). Newby and Zaltsman (1999) recently demonstrated medial proliferation of smooth muscle cells within the organ-cultured rabbit and pig aorta, as well as human saphenous veins. They indicate that organ culture greatly parallels chemotaxis and matrixes remodeling in animal models because of the intact interactions that are present within organ culture. Recently, Voisard et al. (1999) pointed out that organ culture is a valuable model that mimics the injury response of atherosclerosis.

This study uniquely demonstrates that the Cam response mediated by ETA or ETB receptors in isolated smooth muscle cells is paralleled by the development of isometric tension in both cold-stored and organ-cultured coronary arteries. Our results indicate that the 2-fold increase in Cam and tension development to ET-1 with organ culture is attributed to ETA receptors, and not ETB receptors.

    Materials and Methods
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Organ Culture and Single-Cell Fura-2 Digital Imaging. Hearts were obtained from local abattoirs and prepared as described in our laboratory (Sturek et al., 1991). Right coronary arteries (distal end) were either cold stored for 4 days at 5°C or organ cultured for 4 days at 37°C in a 95% O2, 5% CO2 incubator. The arterial segments that were organ cultured or cold stored were opened longitudinally to expose the lumen and placed with the lumen facing up in a 100-mm Petri dish containing 30 ml of RPMI 1640 (Life Technologies, Grand Island, NY). The RPMI 1640 was changed every 2 days.

Smooth muscle cells from cold-stored or organ-cultured arteries were isolated in a vial containing an enzymatic solution, which was replaced every 60 min, with the following composition (Sturek et al., 1991): 294 U/ml collagenase (Worthington, Freehold, NJ), 2 mg/ml bovine serum albumin (Sigma Chemical Co., St. Louis, MO), 1 mg/ml soybean trypsin inhibitor (Worthington), and 0.4 mg/ml DNase I (type IV; Sigma Chemical Co.). After 2 or 3 h the dispersed cells in the collagenase solution primarily contained smooth muscle cells, and were identified morphologically (Wagner-Mann et al., 1992).

Cam levels were measured using the InCa++ calcium imaging system (Intracellular Imaging Inc., Cincinnati, OH), and similar to previously published methods (Sturek et al., 1991, 1992). Briefly, the cells were incubated with 2.5 × 10-6 M fura-2-acetoxymethyl ester at 37°C for 25 min. In those experiments using antagonists, cells were incubated for 1 h with the appropriate concentration of the antagonist before commencing with single-cell digital imaging. A drop of the fura-2-loaded cellular suspension was placed on a coverslip inside a constant flow superfusion chamber (Science Instruments Shop, University of Missouri, Columbia, MO), which was mounted on an inverted epifluorescence microscope (model TMS-F; Nikon, Melville, NY). Cells were allowed to settle and adhere to the coverslip (Fig. 5A, inset) before commencing with the experiments. Fura-2 was excited by 340- and 380-nm light and the emitted fluorescence (510 nm) collected by a monochrome charge-coupled device camera (Cohu, Inc., San Diego, CA) that was attached to a computer for data aquisition by the InCa ratiometric fluorescence program, version 1.2 (Intracellular Imaging Inc.). Data are expressed as a ratio (and indicated as ratio units) of the emitted light intensity at 340- and 380-nm excitation rather than [Ca2+m] because of uncertainties, mainly impaired calcium sensitivity, detailed in previous reports (Sturek et al., 1991, 1992; Wagner-Mann et al., 1991, 1992). An especially important consideration is that the "in situ" calibration is similar for cells from cold-stored and organ-cultured arteries (data not shown); thus, fura-2 fluorescence ratios are directly comparable between groups whether calcium sensitivity is altered or not. The in situ calibration provides a better representation concerning the state of the acetoxymethyl ester form of fura-2 compared with the free acid form of fura-2 in cells in a simplified mock intracellular solution.

DNA Imaging. Cold-stored and organ-cultured arteries were fixed in 4% paraformaldehyde and incubated for 24 h in 30% sucrose at (20°C). Arteries were freeze mounted and cut into 7-µm sections. Cross sections were stained with 2.5 × 10-7 M 4',6-diamidino-2-phenylindole dihydrochloride (DAPI) for 20 min at 37°C to quantitate single-cell DNA content (Kapuscinski, 1995). Imaging of DAPI fluorescence was done using a widefield epifluorescent microscope (Nikon Diaphot, Garden City, NY). Images at three focal planes 0.5 µm apart in the z-axis were acquired for deconvolution analysis. Out-of-focus fluorescence was removed by deconvolution software equipped with a digital signal processing board that used the nearest neighbor algorithm (Vaytek, Inc., Fairfield, IA). DAPI fluorescence was quantitated using Image Pro Plus 3.0 software (Media Cybernetics, Silver Springs, MD).

Isometric Tension Measurements. Similar to the single-cell imaging experiments, porcine right coronary arteries were sectioned and placed in a Petri dish containing RPMI 1640 for cold storage or organ culture. After 4 days, vessel segments were sectioned into 5-mm rings and the endothelium removed using a toothpick. Rings were also further studied within 3 h after the sacrifice of the pig. The absence of an intact endothelium was confirmed by the lack of a relaxation response to 1 × 10-7 M bradykinin. Rings were mounted via two stainless steel wire supports in 25 ml of isolated organ baths maintained at 37°C, and the physiological salt solution (PSS) aerated with a 95% O2, 5% CO2 mixture. The two support wires were connected to an isometric force transducer (Grass Medical Instruments, Quincy, MA) and a linear displacement micrometer (Mitutoyo, MTI Corp., Paramus, NJ). Force generation was amplified by a custom-designed amplifier (Technical Resources Core Facility, Dalton Cardiovascular Research Center), and the data acquired by a computer equipped with an analog-to-digital converter and Labtech Acquire software (Laboratory Technologies Corp., Wilmington, MA). Rings were set near their optimum length-tension relationship by progressively lengthening each ring and subsequently contracting it with the addition of a 60 × 10-3 M KCl solution to the organ bath. This procedure was repeated until the active force generated was no more than 10% greater than at the previous length. Rather than stretching all vessel rings to the same passive tension, the method of setting each vessel at optimal length was chosen to reduce variability and maximize the response of each vessel ring. Rings were initially exposed to an 80 × 10-3 M KCl solution (80K) before exposing them to ET-1. In those experiments using antagonists, cells were incubated for 45 min with the appropriate concentration of the antagonist before generating a cumulative concentration-response relationship to ET-1 in half-log increments (3 × 10-10-3 × 10-7 M).

To normalize each individual arterial response to ET-1, the ET-1-induced tension development is expressed as a percentage of the maximum contractile response generated by 80K. Overall, there was no difference (P > .05) in the absolute tension (grams) developed to 80K in cold-stored and organ-cultured arterial rings.

Solutions. Isolated smooth muscle cells within the superfusion chamber were continually superfused with PSS containing 138 × 10-3 M NaCl, 5 × 10-3 M KCl, 2 × 10-3 M CaCl2, 1 × 10-3 M MgCl2, 10 × 10-3 M HEPES, 10 × 10-3 M glucose, titrated to pH 7.4 (with NaOH). The depolarizing solution (80K or 25 × 10-3 M KCl solution) was composed of 65 × 10-3 M NaCl, 80 or 25 × 10-3 M KCl, 2 × 10-3 M CaCl2, 1 × 10-3 M MgCl2, 10 × 10-3 M HEPES, 10 × 10-3 M glucose, titrated to pH 7.4 (with NaOH). For isometric tension measurements the PSS was similar to that for single cells except that 24 × 10-3 M NaHCO3 was added and NaCl was reduced by 24 × 10-3 M. The stock solution of potassium chloride (Sigma Chemical Co.) was prepared in distilled water. Fura-2-acetoxymethyl ester (Molecular Probes, Inc., Eugene, OR), BQ123 (Peptides International, Louisville, KY), PD145065 (Sigma Chemical Co.), and BQ788 (Peptides International) were prepared in dimethyl sulfoxide (Sigma Chemical Co.). DAPI (Molecular Probes, Inc.) and endothelin-1 (Peninsula Labs, Inc., San Carlos, CA) were prepared in N,N-dimethyl-formamide (Sigma Chemical Co.) and 0.01 N acetic acid, respectively. Bosentan was a gift from Roche Pharmaceuticals (Nutley, NJ). Drugs to be used within the superfusion system were diluted from stock solutions into PSS and superfused at a rate of approximately 2 ml/min.

Statistical Analysis. Data were expressed as the mean ± S.E. for the number (n) of single cells (fura-2 imaging) or animals (isometric tension) within each group. Analysis of data was done by either a one-way ANOVA or a Kruskal-Wallis one-way ANOVA followed by Bonferroni's test or Dunn's test, respectively, when more than two groups were present. A paired or unpaired Student's t test was used when comparing only two groups. Smooth muscle cells that were identified as "responders" to an agonist were defined as those cells whose response to an agonist was at least three standard deviations above the baseline for 5% of the time exposed to the agonist (P < .01). The percentage of responders was analyzed using the chi square distribution. Statistical analyses of the data were performed using SigmaStat (Jandel Scientific Software, San Rafael, CA). The pD2 values (-log EC50) were calculated and analyzed using GraphPad Prism 2.0 (GraphPad Software Inc., San Diego, CA). Significance was defined as P < .05.

    Results
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

A concentration-response relationship (3 × 10-10-3 × 10-7 M) to ET-1 was generated in fresh (n = 8) and cold-stored arterial rings (n = 18). The pD2 values (-log EC50) in fresh and cold-stored rings (7.96 ± 0.23 and 7.60 ± 0.13, respectively) were not significantly different. Additionally, isometric tension development (96 ± 12 and 121 ± 8%, respectively) to a maximal concentration (Tmax) of ET-1 (3 × 10-7 M) was not significantly different between fresh and cold-stored rings. We have previously demonstrated (M. Sturek, B. Hill, and B. Wamhoff, unpublished observations) using isolated single smooth muscle cells from fresh and cold-stored arteries that there is no difference in the basal Cam concentration or the peak Cam response to 5 × 10-3 M caffeine or 80K between groups, suggesting cold-stored arteries serve as an adequate paired time control for those arteries that were organ cultured.

A cumulative concentration-response relationship to ET-1 was generated from 3 × 10-10 to 3 × 10-7 M in arterial rings that had been organ cultured (n = 20). As demonstrated in Fig. 1, organ-cultured rings demonstrated a significant increase (227 ± 20%) in their Tmax to 3 × 10-7 M ET-1 compared with cold-stored rings (121 ± 8%; n = 18). However, there was no difference in potency (pD2) to ET-1 between cold-stored and organ-cultured rings (7.60 ± 0.13 and 7.56 ± 0.03, respectively). The 2-fold increase in the Tmax of organ-cultured rings indicates organ culture may enhance the physiological function of ET receptors to elicit a contraction. To identify whether either the ETA or ETB subtype contributes to this increased tension development, a concentration-response relationship was generated to ET-1 in the absence and presence of bosentan (ETA and ETB antagonist), PD145065 (ETA and ETB antagonist), BQ123 (ETA antagonist), and BQ788 (ETB antagonist).


View larger version (11K):
[in this window]
[in a new window]
 
Fig. 1.   Organ-cultured arterial rings display an enhanced contractile response to ET-1 compared with cold-stored rings. ET-1-induced tension development is expressed as a percentage (%) of the maximum contractile response generated by 80K. *, represents a significant (P < .05) difference from the cold-stored rings.

Bosentan (10-6 M), a nonselective ET antagonist, inhibited isometric tension development to ET-1 in organ-cultured and cold-stored arterial rings as indicated by the significant rightward shift of the concentration-response relationship to ET-1 (Fig. 2; Table 1). In cold-stored rings, the pD2 value in the absence of bosentan was 7.95 ± 0.10. The pD2 could not be calculated in cold-stored rings in the presence of bosentan because a sigmoidal concentration-response relationship was not generated. In organ-cultured rings, the pD2 values in the absence and presence of bosentan were 7.57 ± 0.05 and 6.78 ± 0.14, respectively. Bosentan did not significantly affect the Tmax in organ-cultured and cold-stored rings. In addition, another ETA and ETB antagonist, PD145065 (10-6 M), similarly shifted the ET-1 concentration-response relationship to ET-1 to the right in both cold-stored and organ-cultured rings (data not shown).


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 2.   Antagonism of contractions to ET-1 by bosentan in organ-cultured (OC) and cold-stored (CS) arterial rings. A cumulative concentration-response relationship was generated to ET-1 (3 × 10-10-3 × 10-7 M) in the absence or presence of 10-6 M bosentan in organ-cultured and cold-stored rings. The ET-1-induced tension development is expressed as a percentage (%) of the maximum contractile response generated by 80K. *, indicates a significant (P < .05) difference in tension development from OC + bosentan at each respective ET-1 concentration. and , indicates a significant difference in tension development from CS + bosentan.


                              
View this table:
[in this window]
[in a new window]
 
TABLE 1
Antagonism of ET-1-induced tension development

Selective inhibition of isometric tension development was determined using the selective ETA antagonist BQ123 (Table 1). In cold-stored rings, only 10-5 M BQ123 (Fig. 3A) significantly inhibited the concentration-response relationship to ET-1; no inhibition was demonstrated using 10-6 M BQ123 (Fig. 3B). In contrast, both 10-6 M (Fig. 3B) and 10-5 M (Fig. 3A) BQ123 shifted the concentration-response relationship (i.e., pD2 values) to the right 5- and 7-fold, respectively, in organ-cultured rings. As shown by Fig. 4, selective inhibition of the ETB receptor with BQ788 (10-5 or 10-6 M BQ788) did not alter the pD2 value or the Tmax in the cold-stored and organ-cultured arterial rings (Table 1). Using cardiac fibroblasts we have confirmed the antagonistic activity of BQ788, which contain both ETA and ETB receptors (data not shown).


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 3.   Antagonism of contractions to ET-1 by BQ123 in OC and CS arterial rings. A, inhibition of ET-1-induced tension development by 10-5 M BQ123 in organ-cultured and cold-stored rings. B, inhibition of ET-1-induced tension development by 10-6 M BQ123 in organ-cultured rings. A cumulative concentration-response relationship was generated to ET-1 (3 × 10-10-3 × 10-7 M) in the absence or presence of either 10-5 or 10-6 M BQ123 in organ-cultured and cold-stored rings. The ET-1-induced tension development is expressed as a percentage (%) of the maximum contractile response generated by 80K. *, indicates a significant (P < .05) difference in tension development from OC + BQ123 at each respective ET-1 concentration. and , indicates a significant difference in tension development from CS + BQ123.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 4.   There is no antagonism of ET-1-induced contractions by BQ788 in OC and CS arterial rings. A cumulative concentration-response relationship was generated to ET-1 (3 × 10-10-3 × 10-7 M) in the absence or presence of 10- 5 M BQ788 in organ-cultured and cold-stored rings. The ET-1-induced tension development is expressed as a percentage (%) of the maximum contractile response generated by the 80K.

To further investigate the altered contractile function of ET receptors, smooth muscle cells were enzymatically isolated from both cold-stored and organ-cultured arteries, and the Cam response measured to 3 × 10-8 M ET-1 in the absence and presence of 10-5 M bosentan, BQ123, and BQ788 (Fig. 5, A and B). We used 3 × 10-8 M ET-1 because this was the approximate EC50 value (pD2 = 7.5) for the concentration-response relationship generated to ET-1 in cold-stored and organ-cultured arterial rings. Previous observations indicate that not all cells respond to ET-1 in the absence of an antagonist; however, in evaluating the effect of antagonists on the Cam response all cells (both responders and nonresponders) were pooled. All cells were pooled because it would not be known whether the nonresponders to ET-1 inherently did not respond to ET-1, or whether the antagonist effectively inhibited the Cam response to ET-1. Because our reported results include both responders and nonresponders to ET-1, the reported Cam response to ET-1 will be lower (due to the "dilution" of the Cam response to ET-1 by the nonresponders) than if calculated for just those cells responding to ET-1. Similar to the development of isometric tension in arterial rings, cells from organ-cultured arteries had a significantly increased Cam response to ET-1 (0.50 ± 0.05 ratio units; n = 20) compared with those cells from cold-stored arteries (0.19 ± 0.03 ratio units; n = 24). Bosentan significantly decreased the ET-1-induced Cam response in cells from both cold-stored (0.09 ± 0.02 ratio units; n = 29) and organ-cultured (0.10 ± 0.03 ratio units; n = 14) arteries compared with the paired control cells without bosentan (0.19 ± 0.03 and 0.50 ± 0.05 ratio units, respectively). In cells from organ culture, BQ123 also significantly decreased the Cam response (0.13 ± 0.04 ratio units; n = 14) to similar levels as bosentan. BQ788 had little effect (P > .05) on the ET-1 response (0.37 ± 0.05 ratio units; n = 18) in cells from organ culture. In cells from cold-stored arteries, both BQ123 (0.19 ± 0.04 ratio units; n = 19) and BQ788 (0.27 ± 0.03 ratio units; n = 20) did not significantly decrease the Cam response to ET-1.


View larger version (31K):
[in this window]
[in a new window]
 
Fig. 5.   Inhibition of ET-1-induced increases in myoplasmic calcium by several selective ET-1 antagonists. A, representative tracing from a single smooth muscle cell isolated from an organ-cultured artery and exposed to 3 × 10-8 M ET-1. An example of smooth muscle cells to be digitally imaged is demonstrated in the inset. The black line surrounding a single cell represents the enclosed "area of interest" (i.e., cell area) to be measured and analyzed. B, antagonism of ET-1-induced increases in myoplasmic calcium in isolated smooth muscle cells from cold-stored and organ-cultured arteries. In those experiments using antagonists, cells were incubated for 1 h with 10-5 M of the antagonist before exposing them to 3 × 10-8 M ET-1. *, indicates a significant (P < .05) difference from the no antagonist condition within the organ-cultured or cold-stored group. and , indicates a significant difference from the cold-stored, no-antagonist group.

In agreement with data generated by both isometric tension recordings and single-cell Cam responses to ET-1 in the presence of BQ788, the selective ETB receptor agonist sarafotoxin 6C (10-8 M), did not significantly increase Cam above basal levels in isolated cells from cold-stored and organ-cultured arteries (Fig. 6). Sarafotoxin 6C has been extensively used as an ETB agonist in vascular smooth muscle (Adner et al., 1998a; White et al., 1998). We previously found that 10-8 M sarafotoxin 6C elicited a similar Cam response as 10-7 M sarafotoxin 6C. Previously, we determined that not all cells respond to ET-1 and sarafotoxin 6C; therefore, the Cam response was determined only in those cells that responded to the agonists (Fig. 6). In cells isolated from organ-cultured arteries, 75% (15 of 20) responded to ET-1, whereas only 14% (5 of 35) responded to sarafotoxin 6C. However, in cells from cold-stored arteries, 33% (4 of 12) and 35% (9 of 26) of the cells responded to ET-1 and sarafotoxin 6C, respectively. As shown in Fig. 6, ET-1 elicited a significantly increased Cam response of 0.47 ± 0.10 ratio units above baseline in isolated cells from organ culture compared with the Cam response in cells from cold-stored arteries (0.07 ± 0.03 ratio units). In contrast to ET-1, the Cam response to sarafotoxin 6C was significantly decreased with organ culture (0.04 ± 0.03 ratio units) compared with cold storage (0.11 ± 0.04 ratio units).


View larger version (27K):
[in this window]
[in a new window]
 
Fig. 6.   Organ culture enhances and attenuates the myoplasmic calcium responses to ET-1 and sarafotoxin 6C, respectively, compared with cold storage. Isolated smooth muscle cells from organ-cultured or cold-stored arteries were either exposed to 3 × 10-8 M ET-1 or 10-8 M sarafotoxin 6C. *, indicates a significant (P < .05) difference from the organ culture group exposed to ET-1. and , indicates a significant difference from the organ culture groups exposed to sarafotoxin 6C.

This study, as well as previous studies by our lab (Wagner-Mann and Sturek, 1991, 1992), indicate that the peak Cam response elicited to ET-1 in isolated smooth muscle cells was predominantly due to the release of calcium from the sarcoplasmic reticulum (SR). However, our lab and others (Goto et al., 1989; Wagner-Mann and Sturek, 1991) have shown that ET-1 does appear to induce a very small amount of calcium influx (which has a negligible contribution to the peak Cam response) via voltage-gated calcium channels after the initial release of the SR calcium store. In our study, the minimal contribution of calcium influx to the peak Cam response is demonstrated by the absence of a sustained "plateau" phase after the initial transient calcium spike (due to SR calcium release; Fig. 5A) after ET-1 application in cells from both cold-stored and organ-cultured arteries. In our preparation, this lack of a measurable sustained calcium influx in response to ET-1 is due to the rapid extrusion of calcium from the cell (Rasmussen et al., 1989; Bowles et al., 1995). We demonstrated that ET-1-induced tension development is, in a large part, due to sustained calcium influx by exposing arterial rings to ryanodine (10-5 M) for 50 min, which our lab previously documented mobilizes and fully depletes the SR calcium store (Wagner-Mann and Sturek, 1991, 1992). Subsequent to ryanodine, 5 × 10-8 M ET-1 was applied for 25 min, which induced a significant contractile response.

Cold-stored (Fig. 7A; n = 5) and organ-cultured (Fig. 7B; n = 5) artery sections were stained with DAPI, an indicator of DNA content. DAPI fluorescence has extensively been used to measure nuclear DNA content in cells (Seiler et al., 1993; Kapuscinski, 1995). Previous investigators have confirmed that the relative DAPI fluorescence intensity is directly related to both DNA content (Seiler et al., 1993) and cell proliferation (McCaffrey et al., 1988). There was a significant increase in the amount of DAPI fluorescence in single smooth muscle cells (Fig. 7C) from the cross-sectioned, organ-cultured (164.60 ± 3.55) compared with cold-stored (96.09 ± 2.64) arteries. In addition, DAPI-stained nuclei in organ-cultured cross sections (Fig. 7B) demonstrated a lack of circumferential orientation compared with the circumferentially oriented cold-stored cells (Fig. 7A).


View larger version (64K):
[in this window]
[in a new window]
 
Fig. 7.   Arterial cross sections from organ-cultured arteries exhibit increased DNA content. Cold-stored and organ-cultured arteries were cut into 7-µm sections and incubated with 2.5 × 10-7 M DAPI (DNA stain). A, typical cold-stored artery section stained with DAPI. The white arrows (A and B) indicate DAPI fluorescence of single smooth muscle cells. Cells from cold-stored arteries run circumferentially as indicated by the elongated cell morphology. B, typical organ-cultured artery section stained with DAPI. Compared with A, smooth muscle cells in B are disoriented, which is characteristic of smooth muscle cell migration. C, mean DAPI fluorescence of single smooth muscle cells within each cross section.

    Discussion
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Previous investigators have demonstrated an enhanced expression and function of either the ETA or ETB receptor subtype in different models of arterial injury (Wang et al., 1995; Dagassan et al., 1996; Mathew et al., 1996; Hasdai et al., 1997; Stewart, 1998; Katwa et al., 1999). We hypothesized that there is an enhanced physiological function of ET receptors in an organ culture model of the porcine right coronary artery. Although no studies have directly addressed the possibility that smooth muscle cells may respond differently to ET-1 if they are isolated from the artery itself, this study uniquely demonstrates that isolated single smooth muscle cells respond similarly as those smooth muscle cells possessing cell-cell interactions within the vessel wall. Our results demonstrate that both intact arterial rings and isolated smooth muscle cells display an enhanced response (i.e., tension development and Cam response, respectively) to ET-1 with organ culture. Specifically, this study demonstrates that organ culture enhances the physiological function of ETA receptors in the right coronary artery.

The organ culture model has been extensively used to study cell proliferation and migration (Gotlieb and Boden, 1984; Newby and Zaltsman, 1999; Voisard et al., 1999). We uniquely confirmed that cells from organ-cultured arteries are undergoing cell cycling because in intact arterial cross sections there is a greater DNA content than cells from cold storage. This agrees with investigators who confirmed that the relative DAPI fluorescence intensity positively correlates with cell proliferation (McCaffrey et al., 1988). Furthermore, the DAPI staining in single cells from organ-cultured arterial cross sections demonstrated a lack of orientation compared with the circumferentially oriented cold-stored cells. The cells from organ-cultured arteries appear to be in a migrating state. Recently, organ culture has also been used to study receptor function and density within these proliferating cells, such as happens in atherosclerosis (Adner et al., 1996, 1998a,b). Therefore, we used the organ culture model to determine whether the contractile activity of coronary smooth muscle cells is altered with arterial injury.

Our results indicate that there was no difference in the potency of ET-1 if the artery was organ cultured. Our pD2 values for cold-stored and organ-cultured rings were 7.60 ± 0.13 and 7.56 ± 0.03, respectively (P > .05). This agrees with Harrison et al. (1992) who reported a pD2 value of 8.17 by measuring tension development in endothelium-denuded rings from pig coronary arteries. Because the pD2 values were similar between cold-stored and organ-cultured rings, it might be assumed that a maximal concentration of ET-1 (3 × 10-7 M) would elicit a similar contractile response between groups as was shown by Adner et al. (1995) using fresh and organ-cultured human omental arteries. However, we demonstrated an approximate 2-fold increase in isometric tension development to a maximal concentration of ET-1 in organ-cultured arterial rings compared with cold-stored rings. In addition, using the ET-1 EC50 (as determined in the arterial rings) we showed that ET-1 increased the Cam response 2.6-fold in single cells that were isolated from organ-cultured arteries compared with those isolated from cold-stored arteries. The apparent higher sensitivity to ET-1 in isolated single smooth muscle cells than in intact arterial rings appears to be due to the source of calcium used for tension development. Our data suggest that contractile force is highly dependent on calcium influx, and not SR calcium release. This suggests that the greater contractile force generated in organ-cultured rings is partially attributed to an increase in calcium influx. Other studies have also shown that ET-1-induced calcium influx mediates tension development (Kasuya et al., 1989; Inui et al., 1999). It has been demonstrated that a sustained influx of calcium is matched by calcium extrusion (so-called "calcium cycling"), which returns bulk Cam to basal levels without limiting sustained tension development (Rasmussen et al., 1989; Bowles et al., 1995). Therefore, because the ET-1-induced influx of calcium is rapidly extruded from the cell (Bowles et al., 1995), ET-1-induced calcium influx is not apparent using single-cell digital imaging of bulk Cam. However, we used single-cell fura-2 digital imaging to measure SR calcium release (Wagner-Mann and Sturek, 1991, 1992). Our data suggest that there is a greater enhancement of the ET-1-mediated release of calcium from the SR with organ culture. Investigators have found that the transient ET-1 induced intracellular release of calcium (via inositol triphosphate) appears to be primarily linked to mitogenesis and sensitization of the myofilaments via the activation of protein kinase C (Assender et al., 1996; Schiffrin and Touyz, 1998; Suzuki et al., 1999). Both Douglas et al. (1994) and McKenna et al. (1998) have demonstrated that ET-1 promotes neointimal thickening in arterial injury models. Therefore, the enhanced release of calcium from the SR with organ culture may induce cell proliferation as is demonstrated during atherosclerotic development.

We originally hypothesized that the enhanced tension development and Cam increase in response to ET-1 with organ culture was due, in part, to an enhanced action of ET receptors. This was confirmed using the nonselective ET antagonist bosentan, which inhibited both tension development in arterial rings and the Cam response in isolated single cells. Bosentan shifted the concentration-response relationship to the right 6-fold and inhibited the Cam response by 80% in cells isolated from organ-cultured arteries. Therefore, our results corroborate those reports by investigators who have shown that ET-1 receptors are up- or down-regulated in response to a variety of vascular pathologies and organ culture (Wang et al., 1995; Adner et al., 1996, 1998a,b; Mathew et al., 1996; Stewart, 1998).

We determined the contribution of the ETA receptor subtype in mediating the enhanced contractile and Cam response in organ-cultured arteries using the selective ETA antagonist BQ123. In cold-stored rings 10-6 M BQ123 was ineffective in inhibiting the ET-1 response; only 10-5 M BQ123 inhibited the ET-1 response. In contrast, both 10-6 and 10-5 M BQ123 were effective in shifting the concentration-response relationship 5- and 7-fold to the right, respectively, in organ-cultured rings. This is similar to the 6-fold shift to the right with bosentan in organ-cultured rings. Because 10-6 M BQ123 inhibited and had no effect on organ-cultured and cold-stored rings, respectively, this suggests that the increased contractile response to ET-1 is principally due to ETA receptors in organ-cultured arteries.

Isolated single cells demonstrated a similar sensitivity to BQ123 as displayed by organ-cultured arterial rings. Similar to bosentan, BQ123 decreased the Cam response approximately 80% in cells from organ culture. In cells from cold-stored arteries, BQ123 did not decrease the Cam response, whereas bosentan did decrease Cam by about 50%. In evaluating the effect of the antagonists on the Cam response we pooled both cells that did or did not respond to ET-1 in the absence and presence of the antagonist. Otherwise, in the presence of the antagonist, it would not be known whether the cells inherently did not respond to ET-1, or whether the antagonist effectively inhibited the ET-1 response. This dilution of the response to ET-1 may contribute to the apparent lack of ET-1 inhibition by BQ123 in cells from cold-stored arteries. Because only 33% of the cells from cold-stored arteries responded to ET-1 (no antagonist) this decreased the overall reported Cam response, which makes it difficult to formulate a definitive conclusion regarding the antagonism of the ET-1 Cam response in these cells. In contrast, because 75% of the cells from organ-cultured arteries responded to ET-1 (nonantagonist) there was little dilution of the Cam response to ET-1, therefore the antagonism of ET-1 is more apparent and definitive.

Unlike BQ123, the selective ETB antagonist BQ788 did not inhibit isometric tension development or the Cam response to ET-1 in both intact rings and isolated cells from organ-cultured or cold-stored arteries. In response to the selective ETB agonist sarafotoxin 6C, cells from organ-cultured arteries actually decreased their Cam response 60% compared with cells from cold storage. These Cam data suggest there may be a functional down-regulation of ETB receptors. However, it is difficult to accurately conclude there is a decreased function of ETB receptors with organ culture because our data demonstrate such a small Cam response to sarafotoxin 6C and very little contribution of ETB-mediated tension development in both normal and organ-cultured arteries.

Our results are important because ET receptors have been implicated in atherosclerosis (Mathew et al., 1996) and neointimal formation after balloon angioplasty (Douglas et al., 1994). An oral ETA antagonist reduced neointimal hyperplasia in a porcine model of coronary artery injury (McKenna et al., 1998). In addition, Katwa et al. (1999) found that the expression of ETA receptors is up-regulated in porcine coronary arteries during restenosis. In contrast, Dagassan et al. (1996) described an up-regulation of ETB receptors in atherosclerotic human coronary arteries. However, Dagassan et al. (1996) used the left anterior descending coronary artery, which appears to have a greater percentage of ETB receptors than the right coronary artery (Harrison et al., 1992; Godfraind, 1993; Elmoselhi and Grover, 1997; Hasdai et al., 1997). The right coronary artery, as was used in this study, demonstrates an ETB receptor population that mediates little vasoconstriction (Bacon and Davenport, 1996). Therefore, the right coronary artery is a good model to use to exclusively study the function (i.e., vasoconstriction and Cam response) of ETA receptors.

This study uniquely demonstrates that the Cam response mediated by either the ETA or ETB receptor in isolated smooth muscle cells parallels the development of isometric tension in both cold-stored coronary arteries and organ-cultured coronary arteries. Organ culture greatly enhanced both the Cam response and isometric tension development to ET-1. Our results indicate that the increased response to ET-1 is attributed to an enhanced action of ETA receptors, and not ETB receptors.

    Acknowledgments

We thank Julie Childress and Qicheng Hu for technical assistance.

    Footnotes

Accepted for publication July 31, 2000.

Received for publication May 22, 2000.

1 This study was supported by National Institutes of Health Grants RR13223 and HL62522 (to M.S.) and an American Heart Association Predoctoral Fellowship (to B.J.F.H.).

Send reprint requests to: Michael Sturek, Ph.D., Department of Physiology, MA415 Medical Sciences Building, School of Medicine, University of Missouri, Columbia, MO 65212. E-mail: sturekm{at}missouri.edu

    Abbreviations

ET-1, endothelin-1; ETA, endothelinA; ETB, endothelinB; LAD, left anterior descending coronary artery; Cam, myoplasmic calcium; DAPI, 4',6-diamidino-2-phenylindole dihydrochloride; PSS, physiological salt solution; 80K, 80 × 10-3 M KCl solution; Tmax, response to a maximal concentration of an agonist; SR, sarcoplasmic reticulum; OC, organ culture; CS, cold storage.

    References
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References


0022-3565/00/2952-0484$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
S. A. Kempson, J. M. Edwards, A. Osborn, and M. Sturek
Acute inhibition of the betaine transporter by ATP and adenosine in renal MDCK cells
Am J Physiol Renal Physiol, July 1, 2008; 295(1): F108 - F117.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
C. A. Witczak, B. R. Wamhoff, and M. Sturek
Exercise training prevents Ca2+ dysregulation in coronary smooth muscle from diabetic dyslipidemic yucatan swine
J Appl Physiol, September 1, 2006; 101(3): 752 - 762.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
S. A. Kempson, J. M. Edwards, and M. Sturek
Inhibition of the renal betaine transporter by calcium ions
Am J Physiol Renal Physiol, August 1, 2006; 291(2): F305 - F313.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. K. Maddali, D. H. Korzick, D. L. Tharp, and D. K. Bowles
PKC{delta} Mediates Testosterone-induced Increases in Coronary Smooth Muscle Cav1.2
J. Biol. Chem., December 30, 2005; 280(52): 43024 - 43029.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. Shen, C. I. Seye, M. Wang, G. A. Weisman, P. A. Wilden, and M. Sturek
Cloning, Up-Regulation, and Mitogenic Role of Porcine P2Y2 Receptor in Coronary Artery Smooth Muscle Cells
Mol. Pharmacol., November 1, 2004; 66(5): 1265 - 1274.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. L. Lee, B. R. Wamhoff, L. C. Katwa, H. K. Reddy, D. J. Voelker, J. L. Dixon, and M. Sturek
Increased Endothelin-Induced Ca2+ Signaling, Tyrosine Phosphorylation, and Coronary Artery Disease in Diabetic Dyslipidemic Swine Are Prevented by Atorvastatin
J. Pharmacol. Exp. Ther., July 1, 2003; 306(1): 132 - 140.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. R. Wamhoff, D. K. Bowles, N. J. Dietz, Q. Hu, and M. Sturek
Exercise training attenuates coronary smooth muscle phenotypic modulation and nuclear Ca2+ signaling
Am J Physiol Heart Circ Physiol, December 1, 2002; 283(6): H2397 - H2410.
[Abstract] [Full Text] [PDF]


Home page